SUPN Covered Call Strategy
SUPN (Supernus Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention. Another key product is Oxtellar XR, an extended-release oxcarbazepine designed for the standalone treatment of partial-onset epileptic seizures in patients aged 6 to 17 and adults. The company also offers Qelbree, a selective norepinephrine reuptake inhibitor approved for attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17. For advanced Parkinson's Disease (PD) patients, APOKYN offers acute, intermittent relief during "off" episodes of hypomobility, and XADAGO serves as an adjunctive treatment with levodopa/carbidopa for those experiencing similar off periods. Other offerings include GOCOVRI, which targets dyskinesia in PD patients, and Osmolex ER, used for Parkinson's disease and drug-induced extrapyramidal reactions in adults.
SUPN (Supernus Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $2.78B, a beta of 0.56 versus the broader market, a 52-week range of 41.01-59.68, average daily share volume of 797K, a public-listing history dating back to 2012, approximately 778 full-time employees. These structural characteristics shape how SUPN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.56 indicates SUPN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on SUPN?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
SUPN snapshot
As of August 14, 2026, spot at $48.19, ATM IV 45.60%, IV rank 4.43%, expected move 13.07%. The covered call on SUPN below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 126-day expiry.
Why this covered call structure on SUPN specifically: SUPN IV at 45.60% is on the cheap side of its 1-year range, which means a premium-selling SUPN covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 13.07% (roughly $6.30 on the underlying). The 126-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SUPN expiries trade a higher absolute premium for lower per-day decay. Position sizing on SUPN should anchor to the underlying notional of $48.19 per share and to the trader's directional view on SUPN stock.
SUPN covered call setup
The SUPN covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SUPN at $48.19 on that close, the first option leg uses a $50.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SUPN chain at a 126-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SUPN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $48.19 | long |
| Sell 1 | Call | $50.00 | $4.48 |
SUPN covered call risk and reward
- Net Premium / Debit
- -$4,371.50
- Max Profit (per contract)
- $628.50
- Max Loss (per contract)
- -$4,370.50
- Breakeven(s)
- $43.71
- Risk / Reward Ratio
- 0.144
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
SUPN covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on SUPN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$4,370.50 |
| $10.66 | -77.9% | -$3,305.10 |
| $21.32 | -55.8% | -$2,239.71 |
| $31.97 | -33.7% | -$1,174.31 |
| $42.63 | -11.5% | -$108.91 |
| $53.28 | +10.6% | +$628.50 |
| $63.93 | +32.7% | +$628.50 |
| $74.59 | +54.8% | +$628.50 |
| $85.24 | +76.9% | +$628.50 |
| $95.90 | +99.0% | +$628.50 |
When traders use covered call on SUPN
Covered calls on SUPN are an income strategy run on existing SUPN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
SUPN thesis for this covered call
The market-implied 1-standard-deviation range for SUPN extends from approximately $41.89 on the downside to $54.49 on the upside. A SUPN covered call collects premium on an existing long SUPN position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether SUPN will breach that level within the expiration window. Current SUPN IV rank near 4.43% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SUPN at 45.60%. As a Healthcare name, SUPN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SUPN-specific events.
SUPN covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SUPN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SUPN alongside the broader basket even when SUPN-specific fundamentals are unchanged. Short-premium structures like a covered call on SUPN carry tail risk when realized volatility exceeds the implied move; review historical SUPN earnings reactions and macro stress periods before sizing. Always rebuild the position from current SUPN chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on SUPN?
- A covered call on SUPN is the covered call strategy applied to SUPN (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With SUPN stock at $48.19 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed SUPN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are SUPN covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the SUPN covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 45.60%), the computed maximum profit is $628.50 per contract and the computed maximum loss is -$4,370.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SUPN covered call?
- The breakeven for the SUPN covered call priced on this page is roughly $43.71 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The SUPN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 13.07%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on SUPN?
- Covered calls on SUPN are an income strategy run on existing SUPN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current SUPN implied volatility affect this covered call?
- SUPN ATM IV is at 45.60% with IV rank near 4.43%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.